Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992; 20: 1–97.

Owen MJ, Williams NM, O'Donovan MC . The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004; 9: 14–27.

Flyckt L, Borg J, Borg K, Ansved T, Edman G, Bjerkenstedt L et al. Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia. Biol Psychiatry 2000; 47: 991–999.

Schwarz MJ, Muller N, Riedel M, Ackenheil M . The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med Hypotheses 2001; 56: 483–486.

Haupt DW, Newcomer JW . Abnormalities in glucose regulation associated with mental illness and treatment. J Psychosom Res 2002; 53: 925–933.

Ryan MC, Collins P, Thakore JH . Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160: 284–289.

Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J . Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003; 64: 575–579.

Kirkegaard C, Faber J . The role of thyroid hormones in depression. Eur J Endocrinol 1998; 138: 1–9.

Baumgartner A, Pietzcker A, Gaebel W . The hypothalamic-pituitary-thyroid axis in patients with schizophrenia. Schizophr Res 2000; 44: 233–243.

Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 643, 684–697.

Swatton JE, Prabakaran S, Karp NA, Lilley KS, Bahn S . Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Mol Psychiatry 2004; 9: 128–143.

Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D et al. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med 2006; 3: e428.

Mero N, Van Tol A, Scheek LM, Van Gent T, Labeur C, Rosseneu M et al. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. J Lipid Res 1998; 39: 1493–1502.

Lewis GF . Determinants of plasma HDL concentrations and reverse cholesterol transport. Curr Opin Cardiol 2006; 21: 345–352.

Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL et al. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci USA 2002; 99: 4680–4685.

Thomas EA, Dean B, Scarr E, Copolov D, Sutcliffe JG . Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder. Mol Psychiatry 2003; 8: 167–175.

Yang Y, Wan C, Li H, Zhu H, La Y, Xi Z et al. Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal Chem 2006; 78: 3571–3576.

Thomas EA, George RC, Danielson PE, Nelson PA, Warren AJ, Lo D et al. Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Mol Psychiatry 2003; 8: 950, 983–993.

Reiss AB . Cholesterol and apolipoprotein E in Alzheimer's disease. Am J Alzheimers Dis Other Demen 2005; 20: 91–96.

Bossy-Wetzel E, Schwarzenbacher R, Lipton SA . Molecular pathways to neurodegeneration. Nat Med 2004; 10 (Suppl): S2–S9.

Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004; 41: 351–365.

Onyango IG, Khan SM . Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. Curr Alzheimer Res 2006; 3: 339–349.

Torrey EF, Yolken RH . The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav Immun 2001; 15: 401–410.

Yao JK, Thomas EA, Reddy RD, Keshavan MS . Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Schizophr Res 2005; 72: 259–266.

Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 2006; 3: e327.